Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SHR-1701

🥰Excellent
Catalog No. T73406Cas No. 2891860-17-4
Alias Retlirafusp alfa

SHR-1701 is a novel bifunctional fusion protein composed of a mAb against programmed death ligand 1 (PD-L1) fused with the extracellular domain of TGFβ receptor II. SHR-1701 has antitumour activity and can be used in solid tumour research.

SHR-1701

SHR-1701

🥰Excellent
Catalog No. T73406Alias Retlirafusp alfaCas No. 2891860-17-4
SHR-1701 is a novel bifunctional fusion protein composed of a mAb against programmed death ligand 1 (PD-L1) fused with the extracellular domain of TGFβ receptor II. SHR-1701 has antitumour activity and can be used in solid tumour research.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
SHR-1701 is a novel bifunctional fusion protein composed of a mAb against programmed death ligand 1 (PD-L1) fused with the extracellular domain of TGFβ receptor II. SHR-1701 has antitumour activity and can be used in solid tumour research.
SynonymsRetlirafusp alfa
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
TargetPD-L1/TGFβ
Chemical Properties
Cas No.2891860-17-4
Storage & Solubility Information
Storage-20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy SHR-1701 | purchase SHR-1701 | SHR-1701 cost | order SHR-1701